AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Anastrozole in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Anastrozole 1 mg Tablet** Tablet | B4-8494 | Novartis Nigeria Limited | active | 26 Jul 2028 |
| Anaglob Tablet** Tablet | C4-1788 | Uche St. Pharmaceutical Company Limited | active | 2 Aug 2026 |
Anastrozole — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Anastrozole, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Anastrozole registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.